Abstract: A computer implemented method for assigning executable functions to available processors in a Multiprocessor environment comprising (as an example of a collection of different processing architectures) one or more CPUs and one or more GPUs, the method comprising: providing an input source comprising instructions and data; breaking the input source into data oriented cell and interface objects with processing attributes; assigning the cell and interface objects to one or more of the GPUs and CPUs based on processing attributes and the multiprocessor environment; and producing output data.
Abstract: The present invention is related to an optical recognition system and a method thereof, and more particularly to an optical recognition system and a method that adopts a single-slope analog-to-digital converter to proceed a single-slope analog-to-digital conversion in order to have an image with a wide dynamic range.
Abstract: To provide a material composed mainly of a material derived from dragon fruit having to provide a supplement, a drug, a cosmetic or a food produced by using the material. The invention provides a material derived from dragon fruit, especially, a powder of dragon fruit, and a supplement, a drug, a cosmetic or a food containing the above material as a component.
Type:
Grant
Filed:
January 24, 2011
Date of Patent:
May 12, 2015
Assignee:
University of Putra Malaysia
Inventors:
Sharifah Kharidah Syed Muhammad, Hossein Amin, Jamilah Bakar
Abstract: The invention relates to monoclonal antibodies directed to a particular part of tropomyosin-related kinase B receptor (TrkB) and hybridoma cell lines producing these. Fragments of these antibodies, in particular fragments representing complementarity determining regions (CDRs), and proteins comprising these, are useful in a method of treating cancer, pain, anorexia, anorexia nervosa and/or cachexia.
Abstract: The present invention relates to a functional table for patient transportation, including: a patient supporter which supports a patient laid thereon and allows the patient to be horizontally slidably transported, with its both sides being changed in their angle with respect to a vertical axis of the patient; a support frame which is located in the central bottom of the patient supporter and allows the patient supporter to be vertically moved; a base frame which is connected to the bottom of the support frame and supports the whole of functional table; and at least three transporting wheels which are connected to the base frame and allow the functional table to be freely moved.
Type:
Grant
Filed:
March 4, 2011
Date of Patent:
May 12, 2015
Assignee:
Keimyung University Industry Academic Cooperation Foundation
Abstract: A catalyst including: a support, the support including a mixture of SiO2 and ZrO2; an active ingredient including copper; a first additive including a metal, an oxide thereof, or a combination thereof; and a second additive including Li, Na, K, or a combination thereof. The metal is Mg, Ca, Ba, Mn, Fe, Co, Zn, Mo, La, or Ce. Based on the total weight of the catalyst, the weight percentages of the different components are as follows: SiO2=50-90 wt. %; ZrO2=0.1-10 wt. %; copper=10-50 wt. %; the first additive=0.1-10 wt. %; and the second additive=0.1-5 wt. %.
Abstract: A retractor has an oximeter sensor at its tip, which allows measuring of oxygen saturation of a tissue being retracted by the retractor. The tip includes one or more openings for at least one source and detector. A specific implementation is a spinal nerve root retractor with an oximeter sensor.
Type:
Grant
Filed:
May 21, 2009
Date of Patent:
May 12, 2015
Assignees:
ViOptix, Inc., Regents of the University of California
Inventors:
Jimmy Jian-min Mao, Robert E. Lash, William Lyon, Richard J. Fechter
Abstract: The subject invention provides novel soluble PD-1 (sPD-1) proteins, nucleic acids, and fusion constructs thereof, for enhancing humoral and cell-mediated immunity of a subject. Also provided are therapeutic compositions comprising the sPD-1 proteins, nucleic acids, and fusion constructs of the subject invention. In a preferred embodiment, the therapeutic composition is formulated as a vaccine composition. Advantageously, the sPD-1 proteins, nucleic acids, and therapeutic compositions provide protective immunity against pathogenic infection including HIV infection. In addition, the subject invention can be used in the prevention and/or treatment of tumor or cancer.
Abstract: Implementations and examples of fiber lasers based on fiber laser cavity designs that produce self-similar pulses (“similaritons”) to achieve a pulse spectral bandwidth greater than a gain spectral bandwidth based on a spectral broadening fiber segment and a spectral filter to ensure the proper similariton conditions.
Type:
Grant
Filed:
February 11, 2013
Date of Patent:
May 12, 2015
Assignee:
Cornell University
Inventors:
Frank W. Wise, Andy Chong, William Renninger
Abstract: A superconducting wire includes a linear superconductor and a carbon nanotube structure. The carbon nanotube structure is located on the linear superconductor. The carbon nanotube structure includes a number of carbon nanotubes joined end to end by van der Waals attractive force between and arranged helically along an axial direction of the linear superconductor.
Type:
Grant
Filed:
December 26, 2012
Date of Patent:
May 12, 2015
Assignees:
Tsinghua University, Hon Hai Precision Industry Co., Ltd.
Inventors:
Xiao-Yang Lin, Kai-Li Jiang, Shou-Shan Fan
Abstract: The disclosure provides compounds useful as insect repellents, compositions comprising such repellents, and methods of repelling an arthropod using such compounds and compositions. The disclosure further provides insect traps and method for identifying ligands and cognates for biological molecules.
Type:
Application
Filed:
October 17, 2012
Publication date:
May 7, 2015
Applicant:
The Regents of the University of California
Abstract: One embodiment of the present invention features a poly-phase local oscillator generator combining frequency dividers and direct-injection-locked phase correctors. The poly-phase local oscillator generator comprises a plurality of phase correctors configured to relax frequency and tuning range of a reference local oscillator (LO), and a plurality of frequency dividers, coupled to the phase correctors, configured to offer different frequency segments. The phase correctors are expandable, so that phase accuracy can be optimized by cascading more of themselves.
Type:
Application
Filed:
November 6, 2013
Publication date:
May 7, 2015
Applicant:
University of Macau
Inventors:
Ka-Fai UN, Pui-In MAK, Rui Paulo da Silva MARTINS
Abstract: A substantially enriched mammalian multipotent vascular stem cell (MVSC) population is provided, as well as compositions comprising the population. Methods are provided for the isolation, purification, and culture of the MVSCs. The MVSCs are useful in various applications, which are also provided.
Type:
Application
Filed:
January 29, 2013
Publication date:
May 7, 2015
Applicant:
The Regents of the University of California
Abstract: The invention relates to methods, devices, systems and uses of such systems for the generation and detection of electromagnetic fields carrying orbital angular momentum. An electromagnetic wave placed in a resonator having a closed-loop waveguide supporting a guided wave propagating at resonance with angular order, p, and with an angular grating patterned in the closed-loop waveguide, the angular grating having a integer number, q, of grating elements. The angular grating selectively couples the guided wave mode to a free space radiation mode having an OAM quantity, l, and out-of-plane wave vector component, krad,z, and wherein significant coupling to the grating occurs only when the following wave matching condition is satisfied: l=p?mq where: m is the diffraction order of the angular grating, m=1, 2, 3, . . . ,.
Abstract: Provided herein are methods for inhibiting expression of DOHH in a cell, and for inhibiting hypusination of eIF5A in a cell, the methods comprising contacting a cell with a miRNA or a nucleic acid molecule encoding the miRNA, wherein the miRNA binds to the 3?UTR of the DOHH mRNA and wherein binding results in a reduction in DOHH expression. Also provided are methods for reducing cellular proliferation and for treating diseases associated with abnormal cellular proliferation.
Type:
Application
Filed:
March 8, 2013
Publication date:
May 7, 2015
Applicant:
The University of Western Australia
Inventors:
Peter Leedman, Keith Giles, Michael Epis, Andrew Barker
Abstract: The present invention relates to compounds that may be used to inhibit activation of protein kinase G (“PKG”). It is based, at least in part, on the discovery of the tertiary structure of PKG and the identification of molecules that either bind to the active site of PKG and/or are analogs of balanol.
Type:
Application
Filed:
September 29, 2014
Publication date:
May 7, 2015
Applicant:
The Trustees of Columbia University in the City of New York
Inventors:
Richard Ambron, Ying-Ju Sung, Jeremy Greenwood, Leah Frye, Shi-Xian Deng, Yuli Xie, Donald W. Landry
Abstract: Nanocomposite polymeric hydrogels comprising polyacrylamide (PAAm) formulated in combination with magnetically-susceptible anisotropic microparticles are described, as are method of making and using said hydrogels.
Type:
Application
Filed:
July 19, 2012
Publication date:
May 7, 2015
Applicant:
Tennessee Technological University
Inventors:
Jeffrey W. Thompson, Holly Stretz, Pedro E. Arce
Abstract: The present invention relates to a method for separating semiconductor devices from a substrate using a nanoporous structure, wherein electrochemical etching is carried out in the absence of a surface metal layer, then the surface metal layer is deposited, and then a GaN thin film is transferred onto a metal wafer by means of wafer bonding and lift-off.
Type:
Application
Filed:
February 6, 2013
Publication date:
May 7, 2015
Applicants:
Seoul Viosys Co., Ltd., University Industry Liaison Office of Chonnam National University
Abstract: The disclosure features systems and methods for detecting organic compounds that include: (a) a transfer line; (b) a probe connected to a first end of the transfer line, the probe including an inlet port and a membrane positioned across an opening in the inlet port; (c) an analysis unit connected to a second end of the transfer line; and (d) an electronic controller. The analysis unit can include a valve featuring multiple ports, a first detection unit configured to measure a photoionization current, and a second detection unit configured to identify chemical compounds, and a trap configured to condense chemical compounds from a vapor phase to a liquid phase. The electronic controller is connected to the valve, the first and second detection units, and the trap.
Abstract: A programmable logic circuit architecture using resistive memory elements. The proposed circuit architecture uses the conventional island-based Field Programmable Gate Array (FPGA) architecture, but with novel integration of CMOS-compatible resistive memory elements that can be programmed efficiently. In the proposed architecture, the programmable interconnects of FPGA are redesigned to use only resistive memory elements and metal wires. Then, the interconnects can be entirely fabricated over logic blocks to save area while keeping their architectural functions unchanged, and the programming transistors can be shared among resistive memory elements to save area. Finally, on-demand buffer insertion is proposed as the buffering solution to achieve more speedup.
Type:
Application
Filed:
June 3, 2013
Publication date:
May 7, 2015
Applicant:
The Regents of the University of California